Mitochondrial energy metabolism in heart failure: a question of balance.

The mitochondrion serves a critical role as a platform for energy transduction, signaling, and cell death pathways relevant to common diseases of the myocardium such as heart failure. This review focuses on the molecular regulatory events and downstream effector pathways involved in mitochondrial energy metabolic derangements known to occur during the development of heart failure.

[1]  Laura C. Greaves,et al.  Mitochondrial DNA mutations in human disease , 2006, IUBMB life.

[2]  W. Pierce,et al.  Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. , 2004, American journal of physiology. Endocrinology and metabolism.

[3]  Michael D. Schneider,et al.  Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy , 2004, Nature Medicine.

[4]  M. Chandler,et al.  Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. , 2004, American journal of physiology. Heart and circulatory physiology.

[5]  V. Giguère,et al.  Estrogen-Related Receptor α Directs Peroxisome Proliferator-Activated Receptor α Signaling in the Transcriptional Control of Energy Metabolism in Cardiac and Skeletal Muscle , 2004, Molecular and Cellular Biology.

[6]  Robert W. Taylor,et al.  NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. , 2004, The Journal of clinical investigation.

[7]  J. Neilson,et al.  Calcineurin and Calcium/Calmodulin-dependent Protein Kinase Activate Distinct Metabolic Gene Regulatory Programs in Cardiac Muscle* , 2004, Journal of Biological Chemistry.

[8]  W. Craigen,et al.  Activation of cardiac Cdk9 represses PGC‐1 and confers a predisposition to heart failure , 2004, The EMBO journal.

[9]  N. Metreveli,et al.  Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. , 2004, Diabetes.

[10]  Xiaohui S. Xie,et al.  Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle , 2004 .

[11]  E. Oakeley,et al.  The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Saffitz,et al.  Cardiac-Specific Induction of the Transcriptional Coactivator Peroxisome Proliferator-Activated Receptor &ggr; Coactivator-1&agr; Promotes Mitochondrial Biogenesis and Reversible Cardiomyopathy in a Developmental Stage-Dependent Manner , 2004, Circulation research.

[13]  E. Dufour,et al.  A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  V. Giguère,et al.  A Polymorphic Autoregulatory Hormone Response Element in the Human Estrogen-related Receptor α (ERRα) Promoter Dictates Peroxisome Proliferator-activated Receptor γ Coactivator-1α Control of ERRα Expression* , 2004, Journal of Biological Chemistry.

[15]  R. Scarpulla,et al.  Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. , 2004, Genes & development.

[16]  Jiandie D. Lin,et al.  Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. , 2004, Genes & development.

[17]  Lihong Cheng,et al.  Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. , 2004, Biochemical and biophysical research communications.

[18]  R. Tian.  Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart , 2003, Current hypertension reports.

[19]  G. Muscat,et al.  The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. , 2003, Molecular endocrinology.

[20]  E. Olson,et al.  Skeletal Muscle Reprogramming by Activation of Calcineurin Improves Insulin Action on Metabolic Pathways* , 2003, Journal of Biological Chemistry.

[21]  P. Reynier,et al.  PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma. , 2003, Biochemical and biophysical research communications.

[22]  Y. Kamei,et al.  PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Rottman,et al.  Very-Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency in Mice , 2003, Circulation research.

[24]  I. Momken,et al.  Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles , 2003, The Journal of physiology.

[25]  Jiandie D. Lin,et al.  Bioenergetic Analysis of Peroxisome Proliferator-activated Receptor γ Coactivators 1α and 1β (PGC-1α and PGC-1β) in Muscle Cells* , 2003, Journal of Biological Chemistry.

[26]  J. Schaffer,et al.  Lipotoxicity: when tissues overeat , 2003, Current opinion in lipidology.

[27]  Jiandie D. Lin,et al.  An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Holness,et al.  Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice. , 2003, American journal of physiology. Heart and circulatory physiology.

[29]  P. Puigserver,et al.  Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): Requirement for hepatocyte nuclear factor 4α in gluconeogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. J. van der Vusse,et al.  Peroxisome Proliferator-Activated Receptor (PPAR) &agr; and PPAR&bgr;/&dgr;, but not PPAR&ggr;, Modulate the Expression of Genes Involved in Cardiac Lipid Metabolism , 2003, Circulation research.

[31]  Anastasia Kralli,et al.  The Transcriptional Coactivator PGC-1 Regulates the Expression and Activity of the Orphan Nuclear Receptor Estrogen-Related Receptor α (ERRα)* , 2003, The Journal of Biological Chemistry.

[32]  Jun Ren,et al.  Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. , 2003, Diabetes.

[33]  E. Clementi,et al.  Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide , 2003, Science.

[34]  S. Homma,et al.  Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. , 2003, The Journal of clinical investigation.

[35]  D. Severson,et al.  Chylomicron and palmitate metabolism by perfused hearts from diabetic mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[36]  Xianlin Han,et al.  A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  P. Herrero,et al.  Myocardial Fatty Acid Metabolism: Independent Predictor of Left Ventricular Mass in Hypertensive Heart Disease , 2003, Hypertension.

[38]  M. Hentschke,et al.  PGC-1 and PERC, coactivators of the estrogen receptor-related receptor gamma. , 2002, Biochemical and biophysical research communications.

[39]  L. Nolte,et al.  Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC‐1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  A. Giordano,et al.  Activation and function of cyclin T–Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy , 2002, Nature Medicine.

[41]  Daniel P. Kelly,et al.  Peroxisome Proliferator-activated Receptor Coactivator-1α (PGC-1α) Coactivates the Cardiac-enriched Nuclear Receptors Estrogen-related Receptor-α and -γ , 2002, The Journal of Biological Chemistry.

[42]  William C Stanley,et al.  Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-&agr; in Pacing-Induced Heart Failure , 2002, Circulation.

[43]  P. Herrero,et al.  Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[44]  R. Scarpulla,et al.  Nuclear activators and coactivators in mammalian mitochondrial biogenesis. , 2002, Biochimica et biophysica acta.

[45]  D. Kressler,et al.  The PGC-1-related Protein PERC Is a Selective Coactivator of Estrogen Receptor α* , 2002, The Journal of Biological Chemistry.

[46]  R. Bassel-Duby,et al.  Regulation of Mitochondrial Biogenesis in Skeletal Muscle by CaMK , 2002, Science.

[47]  M. Chandler,et al.  Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions , 2002, Heart Failure Reviews.

[48]  G. Lopaschuk,et al.  Energy Metabolism in the Hypertrophied Heart , 2002, Heart Failure Reviews.

[49]  D. Kelly,et al.  Transcriptional Activation Of Energy Metabolic Switches In The Developing And Hypertrophied Heart , 2002, Clinical and experimental pharmacology & physiology.

[50]  D. Severson,et al.  A Role for Peroxisome Proliferator-activated Receptor α (PPARα) in the Control of Cardiac Malonyl-CoA Levels , 2002, The Journal of Biological Chemistry.

[51]  S. Rabkin,et al.  Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin. , 2002, American journal of physiology. Heart and circulatory physiology.

[52]  Jiandie D. Lin,et al.  Peroxisome Proliferator-activated Receptor γ Coactivator 1β (PGC-1β), A Novel PGC-1-related Transcription Coactivator Associated with Host Cell Factor* , 2002, The Journal of Biological Chemistry.

[53]  O. Frazier,et al.  Metabolic Gene Expression in Fetal and Failing Human Heart , 2001, Circulation.

[54]  H. Taegtmeyer,et al.  Reactivation of Peroxisome Proliferator-activated Receptor α Is Associated with Contractile Dysfunction in Hypertrophied Rat Heart* , 2001, The Journal of Biological Chemistry.

[55]  D. Kelly,et al.  p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α , 2001, The Journal of Biological Chemistry.

[56]  Jiandie D. Lin,et al.  Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. , 2001, Molecular cell.

[57]  P. Razeghi,et al.  Hypoxia in vivo decreases peroxisome proliferator-activated receptor alpha-regulated gene expression in rat heart. , 2001, Biochemical and biophysical research communications.

[58]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[59]  D. Kressler,et al.  Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Huss,et al.  Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. , 2001, The Journal of biological chemistry.

[61]  R. Scarpulla,et al.  PGC-1-Related Coactivator, a Novel, Serum-Inducible Coactivator of Nuclear Respiratory Factor 1-Dependent Transcription in Mammalian Cells , 2001, Molecular and Cellular Biology.

[62]  T. DeGrado,et al.  Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure , 2001, Circulation.

[63]  Daniel S. Ory,et al.  Palmitate-induced Apoptosis Can Occur through a Ceramide-independent Pathway* , 2001, The Journal of Biological Chemistry.

[64]  P. Herrero,et al.  A novel mouse model of lipotoxic cardiomyopathy. , 2001, The Journal of clinical investigation.

[65]  P. Puigserver,et al.  Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[66]  G. Shipley,et al.  Uncoupling protein 3 transcription is regulated by peroxisome proliferator‐activated receptor α in the adult rodent heart , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  N. Larsson,et al.  Mitochondrial myopathies. , 2001, Acta physiologica Scandinavica.

[68]  R. Garesse,et al.  Animal mitochondrial biogenesis and function: a regulatory cross-talk between two genomes. , 2001, Gene.

[69]  D. Severson,et al.  Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. , 2000, American journal of physiology. Endocrinology and metabolism.

[70]  J. Saffitz,et al.  Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. , 2000, The Journal of clinical investigation.

[71]  I. Tabata,et al.  cDNA Cloning and mRNA analysis of PGC-1 in epitrochlearis muscle in swimming-exercised rats. , 2000, Biochemical and biophysical research communications.

[72]  J. Huss,et al.  PPAR signaling in the control of cardiac energy metabolism. , 2000, Trends in cardiovascular medicine.

[73]  T. Ono,et al.  Constitutive Regulation of Cardiac Fatty Acid Metabolism through Peroxisome Proliferator-activated Receptor α Associated with Age-dependent Cardiac Toxicity* , 2000, The Journal of Biological Chemistry.

[74]  D. Kelly,et al.  Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. , 2000, The Journal of clinical investigation.

[75]  H. Taegtmeyer,et al.  Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. , 2000, Journal of molecular and cellular cardiology.

[76]  R. Passier,et al.  CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. , 2000, The Journal of clinical investigation.

[77]  M. Hixon,et al.  Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training. , 2000, Circulation.

[78]  H. Li,et al.  Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[79]  D. J. Heard,et al.  Human ERRgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. , 2000, Molecular endocrinology.

[80]  Rick B. Vega,et al.  The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes , 2000, Molecular and Cellular Biology.

[81]  E. Olson,et al.  Stimulation of Slow Skeletal Muscle Fiber Gene Expression by Calcineurin in Vivo * , 2000, The Journal of Biological Chemistry.

[82]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.

[83]  B. Lowell,et al.  Role of the β3-Adrenergic Receptor and/or a Putative β4-Adrenergic Receptor on the Expression of Uncoupling Proteins and Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 , 1999 .

[84]  M. Stallcup,et al.  Hormone-independent Transcriptional Activation and Coactivator Binding by Novel Orphan Nuclear Receptor ERR3* , 1999, The Journal of Biological Chemistry.

[85]  V. Mootha,et al.  Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.

[86]  D. Kelly,et al.  A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[87]  W. Wahli,et al.  Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting , 1999 .

[88]  D. Murdock,et al.  Up-regulation of Nuclear and Mitochondrial Genes in the Skeletal Muscle of Mice Lacking the Heart/Muscle Isoform of the Adenine Nucleotide Translocator* , 1999, The Journal of Biological Chemistry.

[89]  F. Gonzalez,et al.  The role of the peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac lipid metabolism , 1999 .

[90]  S. Melov,et al.  Mitochondrial disease in mouse results in increased oxidative stress. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[91]  D. Wallace.  Mitochondrial diseases in man and mouse. , 1999, Science.

[92]  D. Kurtz,et al.  Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[93]  F. Recchia,et al.  Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. , 1998, Circulation research.

[94]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[95]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[96]  G. Barsh,et al.  Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice , 1998, Nature Genetics.

[97]  V. Giguère,et al.  The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene , 1997, Molecular and cellular biology.

[98]  J. D. de Vries,et al.  Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. , 1997, Journal of lipid research.

[99]  D. Wallace,et al.  A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator , 1997, Nature Genetics.

[100]  H. Rockman,et al.  A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[101]  D. Kelly,et al.  Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. , 1996, Circulation.

[102]  T. Pineau,et al.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.

[103]  M. Weiner,et al.  Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. , 1995, Circulation.

[104]  M. Christe,et al.  Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. , 1994, Journal of molecular and cellular cardiology.

[105]  G. Lopaschuk,et al.  Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. , 1994, Canadian journal of physiology and pharmacology.

[106]  G. Lopaschuk,et al.  Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. , 1994, The American journal of physiology.

[107]  G. Paolisso,et al.  Total-body and myocardial substrate oxidation in congestive heart failure. , 1994, Metabolism: clinical and experimental.

[108]  H. Taegtmeyer.  Energy metabolism of the heart: from basic concepts to clinical applications. , 1994, Current problems in cardiology.

[109]  R. Scarpulla,et al.  NRF-1, an activator involved in nuclear-mitochondrial interactions, utilizes a new DNA-binding domain conserved in a family of developmental regulators. , 1993, Genes & development.

[110]  A. Torroni,et al.  Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. , 1992, The Journal of biological chemistry.

[111]  M. Parisi,et al.  DNA wrapping and bending by a mitochondrial high mobility group-like transcriptional activator protein. , 1992, The Journal of biological chemistry.

[112]  G. Lopaschuk,et al.  Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. , 1989, Biochimica et biophysica acta.

[113]  A. Schapira,et al.  Mitochondrial myopathies. , 1989, BMJ.

[114]  H. Taegtmeyer,et al.  Effects of moderate hypertension on cardiac function and metabolism in the rabbit. , 1988, Hypertension.

[115]  R. Evans,et al.  Identification of a new class of steroid hormone receptors , 1988, Nature.

[116]  M. Mayr,et al.  Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. , 1987, The Journal of clinical investigation.

[117]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[118]  L. Opie,et al.  Fatty Acid and Glucose Metabolism in the Perfused Heart , 1961, Nature.

[119]  R. Bing,et al.  Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism. , 1954, The American journal of medicine.

[120]  E. Oakeley,et al.  The estrogen-related receptor ( ERR ) functions in PPAR coactivator 1 ( PGC-1 )-induced mitochondrial biogenesis , 2004 .

[121]  E. Clementi,et al.  Mitochondrial biogenesis as a cellular signaling framework. , 2004, Biochemical pharmacology.

[122]  B. Staels,et al.  Peroxisome Proliferator-Activated Receptor (PPAR) (cid:1) and PPAR (cid:2) / (cid:3) , but not PPAR (cid:4) , Modulate the Expression of Genes Involved in Cardiac Lipid Metabolism , 2003 .

[123]  Xianlin Han,et al.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.

[124]  Q. Liang,et al.  Overexpression of metallothionein reduces diabetic cardiomyopathy. , 2002, Diabetes.

[125]  J. C. Gomez,et al.  Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-alpha in Pacing-Induced Heart Failure , 2002 .

[126]  R. Nohara,et al.  A nuclear complex containing PPARα/RXRα is markedly downregulated in the hypertrophied rat left ventricular myocardium with normal systolic function , 2000, Heart and Vessels.

[127]  S. Bishop,et al.  Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. , 1970, The American journal of physiology.